Davis Polk, Goodwin Steer $1.1B Novo Nordisk Acquisition

By Elaine Briseño (September 1, 2022, 8:16 PM EDT) -- Davis Polk & Wardwell LLP-led Novo Nordisk will acquire Goodwin Procter LLP-advised Forma Therapeutics Holdings Inc., which develops treatments for sickle cell disease and rare blood disorders, for a total equity value of $1.1 billion, the companies announced Thursday....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!